These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Comparison of the BACTEC MGIT 960 with Löwenstein-Jensen medium for recovery of mycobacteria from clinical specimens. Chien HP; Yu MC; Wu MH; Lin TP; Luh KT Int J Tuberc Lung Dis; 2000 Sep; 4(9):866-70. PubMed ID: 10985656 [TBL] [Abstract][Full Text] [Related]
25. The case for hypervirulence through gene deletion in Mycobacterium tuberculosis. ten Bokum AM; Movahedzadeh F; Frita R; Bancroft GJ; Stoker NG Trends Microbiol; 2008 Sep; 16(9):436-41. PubMed ID: 18701293 [TBL] [Abstract][Full Text] [Related]
26. A study of primary drug resistance in pulmonary tuberculosis in west Malaysia 1984-1987. Jalleh RD; Kuppusamy I; Soshila R; Aziah AM; Faridza MY Med J Malaysia; 1993 Jun; 48(2):113-6. PubMed ID: 8350784 [TBL] [Abstract][Full Text] [Related]
27. [The role of L variants of Mycobacteria in the development and clinical course of recurrences of pulmonary tuberculosis]. Berezovskiĭ BA; Salobaĭ RIu Probl Tuberk; 1988; (4):32-5. PubMed ID: 3138685 [No Abstract] [Full Text] [Related]
28. PhoP, a key player in Mycobacterium tuberculosis virulence. Ryndak M; Wang S; Smith I Trends Microbiol; 2008 Nov; 16(11):528-34. PubMed ID: 18835713 [TBL] [Abstract][Full Text] [Related]
29. [Changes in the expert's assessment of tuberculosis. Traditional medical attitudes in expert testimony must be brought in line with the reality of improved therapy and prognosis]. Wandelt-Freerksen E Fortschr Med; 1982 Mar; 100(12):530-2. PubMed ID: 6804344 [No Abstract] [Full Text] [Related]
30. [Characteristics of the course of newly diagnosed tuberculosis in adolescents]. Kratule RV; Medne NA Probl Tuberk; 1982 Jul; (7):45-8. PubMed ID: 7134208 [No Abstract] [Full Text] [Related]
32. [Macrophage activity in anti-Mycobacterium immunity. II. Direct contact of Mycobacterium tuberculosis with the macrophage]. Lipińska R Pneumonol Pol; 1982 Oct; 50(10):535-9. PubMed ID: 6820496 [No Abstract] [Full Text] [Related]
33. [Biological criteria for determination of recovery from tuberculosis]. Lucchesi M; Mancini P Lotta Tuberc; 1971; 41(4):547-53. PubMed ID: 5004580 [No Abstract] [Full Text] [Related]
34. [Pathomorphological characteristics of tuberculosis in relation to the variability of the causative agent]. Puzik VI; Zemskova ZS; Dorozhkova IR; Nurusheva AM Probl Tuberk; 1981 Jul; (7):50-4. PubMed ID: 6792629 [No Abstract] [Full Text] [Related]
35. [Expert testimony in health insurance. VII]. von Keitz W Med Welt; 1966 Jun; 26():1420-7. PubMed ID: 5962715 [No Abstract] [Full Text] [Related]
36. [Medical expert testimony in the health insurance]. Schmidt J Landarzt; 1968 May; 4(13):627-9. PubMed ID: 5731716 [No Abstract] [Full Text] [Related]
38. [Progressing of pulmonary tuberculosis and the frequency of histological identification of Mycobacterium tuberculosis in caseation]. Tkachuk VI Probl Tuberk; 1971; 49(7):71-6. PubMed ID: 5004350 [No Abstract] [Full Text] [Related]
39. [Medical expert testimony in the accident insurance]. Lob A Landarzt; 1968 May; 44(13):637-43. PubMed ID: 5716445 [No Abstract] [Full Text] [Related]
40. [Medical expert testimony in the pension insurance]. Kulpe W Landarzt; 1968 May; 44(13):629-37. PubMed ID: 5716444 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]